This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by National Institute of Health. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: May C Malicdan: Innovator in Sialylation-Increasing Therapies
Introduction
May C Malicdan is a notable inventor based in Rockville, MD (US). She has made significant contributions to the field of medical therapies, particularly in addressing diseases associated with oxidative stress. Her innovative approaches have the potential to improve treatment outcomes for various vascular and cardiac disorders.
Latest Patents
May C Malicdan holds 1 patent for her work titled "Sialylation-increasing therapies for diseases associated with oxidative stress." This patent discloses methods for treating subjects with vascular or cardiac disorders linked to oxidative stress. Additionally, it outlines therapies for GNE myopathy, which is characterized by impaired cardiac function. The methods involve administering therapeutically effective amounts of specific acids or sialylated compounds, including mannosamine and N-acetyl mannosamine, or their derivatives. Furthermore, the patent includes methods for detecting disorders associated with oxidative stress.
Career Highlights
May C Malicdan is affiliated with the National Institutes of Health, where she contributes her expertise to advancing medical research and therapies. Her work is pivotal in developing innovative solutions for complex health issues, particularly those related to oxidative stress.
Collaborations
May C Malicdan collaborates with esteemed colleagues, including Marjan Huizing and Nuria Carrillo. These partnerships enhance the research and development of effective therapies in her field.
Conclusion
May C Malicdan's contributions to sialylation-increasing therapies represent a significant advancement in the treatment of oxidative stress-related diseases. Her innovative work continues to pave the way for improved medical interventions and better patient outcomes.